Investigation of CA15-3 and IgE in Iraqi lung cancer patients: A biochemical and immunological analysis
Investigation of CA 15-3, IgE lung cancer
DOI:
https://doi.org/10.29409/12b2ep92Keywords:
ADA, CA 15 - 3 , HbA1c, IgE, lung cancerAbstract
Introduction: Lung cancer (LC) is one of the leading causes of cancer death worldwide. A number of single nucleotide polymorphisms are associated with the risk of LC, which deserves to be studied further. Aim: The purpose of this study was to identify immunological and biochemical markers for Iraqi lung cancer patients. Method: Fifty LC Iraqi patients and 50 apparently healthy people, who composed the control group, were involved in the study. Blood samples were used for biochemical and immunological studies. DNA extraction and polymorphism of the EXO1 and CHRNA5 genes were carried out via polymerase chain reaction. Results: Lactate dehydrogenase (LDH), blood urea, and serum creatinine levels were significantly greater (P≤0.01) in LC patients compared with control.
In contrast, adenosine deaminase (ADA), HbA1c, and Hb were significantly decreased. Moreover, the levels of immunoglobulin-E (IgE) and cancer antigen 15–3 (Ca-15-3) are increased in LC patients. Scanning the EXO1 gene revealed that the percentage of the mutant homozygous (AA) and (GA) genotypes is greater than that of the wild-type homozygous (GG) genotypes. Homozygous (GG) was highly significant in the control group than other genotypes (AA and GA). Conversely, the CHRNA5 gene revealed that, in comparison with other genotypes (GA, GG), the AA genotype was considerably greater in LC patients. However, the number of homozygous GG genotypes was more significant in the control group than in other groups. EXO1 and CHRNA5 were significantly higher in all the biochemical markers associated with the mutant (AA) genotype. While they were significantly normal in the GG genotype, they also decreased in ADA, HbA1c, and Hgb. IgE was significantly increased in all genotypes.
References
Shim, S. H., Seo, H. J., Seo, H. B., Cho, I. H., Lee, C., Kim, S. Y., ... & Choi, J. Y. (2019). Traditional Korean Medicine for Non-Small Cell Lung Cancer Patient Undergoing Pembrolizumab Immunotherapy: A Case Report. The Journal of Internal Korean Medicine, 40(4), 709-722.
Larsen, J. E., & Minna, J. D. (2011). Molecular biology of lung cancer: clinical implications. Clinics in chest medicine, 32(4), 703.
Binesh, F., Jalali, H., Zare, M. R., Behravan, F., Tafti, A. D., Behnaz, F., ... & Shahcheraghi, S. H. (2016). Diagnostic value of sputum adenosine deaminase (ADA) level in pulmonary tuberculosis. Germs, 6(2), 60.
Dimakou, K., Hillas, G., & Bakakos, P. (2009). Adenosine deaminase activity and its isoenzymes in the sputum of patients with pulmonary tuberculosis. The International journal of tuberculosis and lung disease, 13(6), 744-748.
Farazi, A., Moharamkhani, A., & Sofian, M. (2013). Validity of serum adenosine deaminase in diagnosis of tuberculosis. Pan African Medical Journal, 15(1).
Zhang, M., Li, X., Zhang, X., Yang, Y., Feng, Z., & Liu, X. (2014). Association of serum hemoglobin A1c, C-peptide and insulin-like growth factor-1 levels with the occurrence and development of lung cancer. Molecular and clinical oncology, 2(4), 506-508.
Will, J. C., Vinicor, F., & Calle, E. E. (1999). Is diabetes mellitus associated with prostate cancer incidence and survival?. Epidemiology, 10(3), 313-318.
De Beer, J. C., & Liebenberg, L. (2014). Does cancer risk increase with HbA1c, independent of diabetes?. British journal of cancer, 110(9), 2361-2368.
Zhang, Y., Tang, H., Li, J., & Li, M. (2015). An active treatment of lung adenocarcinoma cancer with brain metastases: icotinib. OncoTargets and therapy, 1351-1354.
Hope, C., Robertshaw, A., Cheung, K. L., Idris, I., & English, E. (2016). Relationship between HbA1c and cancer in people with or without diabetes: a systematic review. Diabetic Medicine, 33(8), 1013-1025.
Karlin, N. J., Amin, S. B., Buras, M. R., Kosiorek, H. E., Verona, P. M., & Cook, C. B. (2018). Patient outcomes from lung cancer and diabetes mellitus: a matched case–control study. Future science OA, 4(1), FSO248.
Kong, M., Lim, Y. J., Kim, Y., Chung, M. J., Min, S., Shin, D. O., & Chung, W. (2019). Diabetes mellitus is a predictive factor for radiation pneumonitis after thoracic radiotherapy in patients with lung cancer. Cancer Management and Research, 7103-7110.
Xiao, T., Ying, W., Li, L., Hu, Z., Ma, Y., Jiao, L., ... & Cheng, S. (2005). An approach to studying lung cancer-related proteins in human blood. Molecular & cellular proteomics, 4(10), 1480-1486.
Ghosh, I., Bhattacharjee, D., Das, A. K., Chakrabarti, G., Dasgupta, A., & Dey, S. K. (2013). Diagnostic role of tumour markers CEA, CA15-3, CA19-9 and CA125 in lung cancer. Indian Journal of Clinical Biochemistry, 28, 24-29.
Shitrit, D., Zingerman, B., Shitrit, A. B. G., Shlomi, D., & Kramer, M. R. (2005). Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature. The Oncologist, 10(7), 501-507.
LIU, Yung-Ching, et al. Differential diagnosis of tuberculous and malignant pleurisy using pleural fluid adenosine deaminase and interferon gamma in Taiwan. Journal of Microbiology, Immunology and Infection, 2011, 44.2: 88-94.
Rittmeyer, D., & Lorentz, A. (2012). Relationship between allergy and cancer: an overview. International archives of allergy and immunology, 159(3), 216-225.
Ding, H., Liu, J., Xue, R., Zhao, P., Qin, Y., Zheng, F., & Sun, X. (2014). Transthyretin as a potential biomarker for the differential diagnosis between lung cancer and lung infection. Biomedical reports, 2(5), 765-769.
Salmanzadeh, S., Tavakkol, H., Bavieh, K., & Alavi, S. M. (2015). Diagnostic value of serum adenosine deaminase (ADA) level for pulmonary tuberculosis. Jundishapur journal of microbiology, 8(3), e21760.
Liu, Y. C., Lee, S. S. J., Chen, Y. S., Tu, H. Z., Chen, B. C., & Huang, T. S. (2011). Differential diagnosis of tuberculous and malignant pleurisy using pleural fluid adenosine deaminase and interferon gamma in Taiwan. Journal of Microbiology, Immunology and Infection, 44(2), 88-94.
Fukui, T., Itabashi, M., Ishihara, M., Hiyoshi, Y., Kasajima, M., Igawa, S., ... & Masuda, N. (2016). Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer. BMC cancer, 16, 1-7.
İnal, T., Anar, C., Polat, G., Ünsal, İ., & Halilçolar, H. (2015). The prognostic value of D‐dimer in lung cancer. The clinical respiratory journal, 9(3), 305-313.
Zhang, M., Zhao, D., Yan, C., Zhang, L., & Liang, C. (2016). Associations between nine polymorphisms in EXO1 and cancer susceptibility: a systematic review and meta-analysis of 39 case-control studies. Scientific reports, 6(1), 29270.
Koukourakis, M. I., Giatromanolaki, A., Sivridis, E., Bougioukas, G., Didilis, V., Gatter, K. C., & Harris, A. L. (2003). Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. British journal of cancer, 89(5), 877-885.
Lee, D. S., Park, K. R., Kim, S. J., Chung, M. J., Lee, Y. H., Chang, J. H., ... & Kim, Y. S. (2016). Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes. Tumor Biology, 37, 619-625.
Koukourakis, M. I., Giatromanolaki, A., & Sivridis, E. (2003). Lactate dehydrogenase isoenzymes 1 and 5: differential expression by neoplastic and stromal cells in non-small cell lung cancer and other epithelial malignant tumors. Tumor biology, 24(4), 199-202.
Winter, M. C., Potter, V. A., & Woll, P. J. (2008). Raised serum urea predicts for early death in small cell lung cancer. Clinical Oncology, 20(10), 745-750.
Lucarelli, G., Ferro, M., Ditonno, P., & Battaglia, M. (2018). The urea cycle enzymes act as metabolic suppressors in clear cell renal cell carcinoma. Translational Cancer Research, 7(Suppl 7).
Suzuki, K., Furuse, H., Tsuda, T., Masaki, Y., Okazawa, S., Kambara, K., ... & Tobe, K. (2015). Utility of creatinine/cystatin C ratio as a predictive marker for adverse effects of chemotherapy in lung cancer: a retrospective study. Journal of International Medical Research, 43(4), 573-582.
Usmani, S. Z., Shahid, Z., Nasser, K. A., & Saleh, H. (2007). Myeloid sarcoma presenting with acute renal failure and bilateral ureteral obstruction: a case report and review of the literature. The American journal of the medical sciences, 334(2), 136-138.
Brant, W. E., & Helms, C. (2012). Diagnostic imaging methods. U: Brant WE, Helms CA. Fundamentals of diagnostic radiology-4th ed. LWW, 2-25.
Wen, Y. K., & Chen, M. L. (2006). Acute renal failure secondary to small cell lung cancer with tumor infiltration of the kidneys. Renal failure, 28(3), 261-264.
Kong, M., Lim, Y. J., Kim, Y., Chung, M. J., Min, S., Shin, D. O., & Chung, W. (2019). Diabetes mellitus is a predictive factor for radiation pneumonitis after thoracic radiotherapy in patients with lung cancer. Cancer Management and Research, 7103-7110.
Aapro, M., Jelkmann, W., Constantinescu, S. N., & Leyland-Jones, B. (2012). Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer. British journal of cancer, 106(7), 1249-1258.
Banzet, S., Sanchez, H., Chapot, R., Bigard, X., Vaulont, S., & Koulmann, N. (2012). Interleukin-6 contributes to hepcidin mRNA increase in response to exercise. Cytokine, 58(2), 158-161.
Wu, Y., Antony, S., Meitzler, J. L., & Doroshow, J. H. (2014). Molecular mechanisms underlying chronic inflammation-associated cancers. Cancer letters, 345(2), 164-173.
Schwab, L. P., Peacock, D. L., Majumdar, D., Ingels, J. F., Jensen, L. C., Smith, K. D., ... & Seagroves, T. N. (2012). Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer. Breast Cancer Research, 14, 1-25.
Tefferi, A., Hudgens, S., Mesa, R., Gale, R. P., Verstovsek, S., Passamonti, F., ... & Khan, Z. M. (2014). Use of the functional assessment of cancer therapy− anemia in persons with myeloproliferative neoplasm-associated myelofibrosis and anemia. Clinical therapeutics, 36(4), 560-566.
Li, S., Meng, W., Guan, Z., Guo, Y., & Han, X. (2016). The hypoxia-related signaling pathways of vasculogenic mimicry in tumor treatment. Biomedicine & Pharmacotherapy, 80, 127-135.
Milane, L., Duan, Z., & Amiji, M. (2011). Role of hypoxia and glycolysis in the development of multi-drug resistance in human tumor cells and the establishment of an orthotopic multi-drug resistant tumor model in nude mice using hypoxic pre-conditioning. Cancer cell international, 11, 1-16.
Rittmeyer, D., & Lorentz, A. (2012). Relationship between allergy and cancer: an overview. International archives of allergy and immunology, 159(3), 216-225.
Ly, D., Zhu, C. Q., Cabanero, M., Tsao, M. S., & Zhang, L. (2017). Role for high-affinity IgE receptor in prognosis of lung adenocarcinoma patients. Cancer Immunology Research, 5(9), 821-829.
Hagströmer, L., Ye, W., Nyrén, O., & Emtestam, L. (2005). Incidence of cancer among patients with atopic dermatitis. Archives of dermatology, 141(9), 1123-1127.
Santillan, A. A., Camargo, C. A., & Colditz, G. A. (2003). A meta-analysis of asthma and risk of lung cancer (United States). Cancer Causes & Control, 14, 327-334.
VESTERINEN, E., PUKKALA, E., TIMONEN, T., & AROMAA, A. (1993). Cancer incidence among 78 000 asthmatic patients. International journal of epidemiology, 22(6), 976-982.
Hwang, C. Y., Chen, Y. J., Lin, M. W., Chen, T. J., Chu, S. Y., Chen, C. C., ... & Liu, H. N. (2012). Cancer risk in patients with allergic rhinitis, asthma and atopic dermatitis: a nationwide cohort study in Taiwan. International journal of cancer, 130(5), 1160-1167.
Chen, Z. Q., Huang, L. S., & Zhu, B. (2018). Assessment of seven clinical tumor markers in diagnosis of non‐small‐cell lung cancer. Disease Markers, 2018(1), 9845123.
Liu, X. Q., Ren, H. X., & Wu, Z. P. (2008). Detecting MUC-1 mRNA for diagnosing peripheral blood micro-metastasis in non-small cell lung cancer patients. Ai Zheng= Aizheng= Chinese Journal of Cancer, 27(12), 1267-1270.
Kong, M., & Lim, Y. J. (2021). Hemoglobin A1c level is a prognostic factor for locoregional recurrence in stage III non‐small cell lung cancer patients treated with radiotherapy. Thoracic Cancer, 12(22), 3032-3038.
Hua, J., Lin, H., Wang, X., Qian, Z. M., Vaughn, M. G., Tabet, M., ... & Lin, H. (2024). Associations of glycosylated hemoglobin, pre-diabetes, and type 2 diabetes with incident lung cancer: A large prospective cohort study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 18(2), 102968.
Luo, W., Guo, T., Li, G., Liu, R., Zhao, S., Song, M., ... & Qin, Y. (2020). Variants in homologous recombination genes EXO1 and RAD51 related with premature ovarian insufficiency. The Journal of Clinical Endocrinology & Metabolism, 105(10), e3566-e3574.
Luo, Z., Wang, W., Li, F., Songyang, Z., Feng, X., Xin, C., ... & Xiong, Y. (2019). Pan-cancer analysis identifies telomerase-associated signatures and cancer subtypes. Molecular cancer, 18, 1-15.
Zhong, Q., Chen, X., Zhao, Y., Liu, R., & Yao, S. (2017). Association of polymorphisms in pharmacogenetic candidate genes with propofol susceptibility. Scientific reports, 7(1), 3343.
Downloads
Received
Revised
Accepted
Published
Data Availability Statement
All data were ready any time if requested.
Issue
Section
License
Copyright (c) 2025 Iraqi Journal of Cancer and Medical Genetics
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
